Post-Market Clinical Follow-Up (PMCF) Study Evaluating the Safety and Efficacy of Tıpmed™ Revision Hip Prosthesis System

This is a multicenter, prospective, observational, post-market clinical follow-up (PMCF) study designed to evaluate the safety and clinical performance of the Tipmed™ Revision Hip Prosthesis System in adult participants undergoing revision hip arthroplasty. The study aims to gather real-world clinical evidence on the 24-month post-operative safety profile, potential complications, and functional outcomes of the device during routine clinical practice.

Inclusion Criteria: * Individuals aged 18 years and older, * Male or female participants, * Participants who have undergone Revision Hip Arthroplasty (either total revision or partial component revision) for any indication (such as a documented joint failure or prosthesis-related clinical complication), * Participants in whose revision procedure the Tıpmed™ Revision Hip Prosthesis System components were utilized, * Participants who are not legally restricted (e.g., military personnel, convicts, or individuals under legal guardianship), * Participants who have voluntarily signed the written Informed Consent Form (ICF). Exclusion Criteria: * Subjects currently participating in any other interventional clinical trial.